Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

By | March 10, 2021
A team of scientists from the USA and Canada has recently characterized the antibodies developed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in response to an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.